The goal of the Breast Oncology Program is to support and stimulate basic, clinical, and population research in breast cancer and to facilitate the translation of these findings into improved cancer management and control.
The Cancer Control Program focuses on social, behavioral, communications, and health policy research, integrating it with cancer research across the spectrum from the basic to the population sciences.
The goal of the Cancer Genetics Program is to elucidate the genetics of tumor susceptibility, tumorigenesis, and progression, and to use this information clinically to improve cancer management.
The Cancer Immunology Program supports research revealing insights into the interactions between evolving neoplastic cells with activated non-neoplastic host cells, and with soluble or insoluble components of extracellular matrix, as well as studies based on these interactions that foster development of novel cellular or molecular-based strategies to combat cancer.
The Experimental Therapeutics Program brings together basic cancer biologists and physician scientists to discover and test novel compounds and treatment strategies for cancer.
The Hematopoietic Malignancies Program aims to develop more effective and less toxic therapeutics for hematopoietic cancers; investigate the genetic and environmental causes of hematologic cancers; and educate trainees, health care professionals, patients, and the public about leukemia, lymphoma, and myeloma.
The Neurologic Oncology Program aims to impact the diagnosis and treatment of brain cancer using a team approach.
The goal of the Pediatric Malignancies Program is to improve the outcome for children with cancer by investigating links between normal development and the aberrant signaling networks of childhood malignancies, and to leverage these genetic networks to identify new therapeutic targets that we integrate into innovative clinical trials.
The Prostate Cancer Program promotes interdisciplinary research to support the development of novel management and intervention strategies to improve the lives of men with prostate cancer.
The goal of the Tobacco Control Program is to eradicate the use of tobacco and tobacco-induced cancer and other diseases worldwide.